| General Information of Drug Metabolite (DM) (ID: DM003245) |
| DM Name |
Mitiglinide carboxyl-glucuronide
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
UDP-glucuronosyltransferase 1A3 (UGT1A3)
|
DME0041
|
| Conjugation - Conjugation |
KAD-1229
|
[1] |
|
UDP-glucuronosyltransferase 2B7 (UGT2B7)
|
DME0040
|
| Conjugation - Conjugation |
KAD-1229
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| KAD-1229 |
DR1100
|
Phase 3 |
Diabetes mellitus |
|
|
| References |
| 1 |
Mitiglinide: a rapid- and short-acting non-sulfonylurea insulinotropic agent for the treatment of type 2 diabetic patients
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
